The DOI matches its Crossref record; 770 of the 770 references it cites were found in a registry or an index.
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
Open accessAbstract
Virus-like particle (VLP) technology is a promising approach for the construction of novel vaccines, diagnostic tools, and gene therapy vectors. Initially, VLPs were primarily derived from non-enveloped icosahedral or helical viruses and proved to be viable vaccine candidates due to their effective presentation of epitopes in a native conformation. VLP technology has also been used to prepare chimeric VLPs decorated with genetically fused or chemically coupled epitope stretches selected from immunologically defined target proteins. However, structural constraints associated with the rigid geometrical architecture of icosahedral or helical VLPs pose challenges for the expression and presentation of large epitopes. Complex VLPs derived from non-symmetric enveloped viruses are increasingly being used to incorporate large epitopes and even full-length foreign proteins. Pleomorphic VLPs derived from influenza or other enveloped viruses can accommodate multiple full-length and/or chimeric proteins that can be rationally designed for multifunctional purposes, including multivalent vaccines. Therefore, a second generation of VLP carriers is represented by complex particles reconstructed from natural or chimeric structural proteins derived from complex enveloped viruses. Further development of safe and efficient VLP nanotechnology may require a rational combination of both approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 401–600 of 770
Vimentin: the conundrum of the intermediate filament gene family
Evans, R. M. (1998) · BioEssays · doi:10.1002/(sici)1521-1878(199801)20:1<79::aid-bies11>3.0.co;2-5 · Cited by 146
Hersey, P., Coates, A. S., McCarthy, W. H., Thompson, J. F., Sillar, R., McLeod, R., Gill, P. G., Coventry, B. J., McMullen, A., Dillon, H., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.12.094 · Cited by 146
Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate
Salcedo, M., Bercovici, N., Taylor, R. R., Vereecken, P., Massicard, S., Duriau, D., Vernel-Pauillac, F., Boyer, A., Baron‐Bodo, V., Mallard, E., et al. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0078-6 · Cited by 145
Expanded HIV-1 Cellular Tropism by Phenotypic Mixing with Murine Endogenous Retroviruses
Lusso, P., Veronese, F. D. M., Ensoli, B., Franchini, G., Jemma, C., DeRocco, S. E., Kalyanaraman, V. S., & Gallo, R. C. (1990) · Science · doi:10.1126/science.2305256 · Cited by 145
Genome Replication and Packaging of Segmented Double-Stranded RNA Viruses
Patton, J. T., & Spencer, E. (2000) · Virology · doi:10.1006/viro.2000.0645 · Cited by 145
Zhang, P. C., Zhong, L., Struble, E. B., Watanabe, H., Kachko, A. V., Mihalik, K., Virata, M. L., Alter, H. J., Feinstone, S. M., & Major, M. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902749106 · Cited by 145
Klimek, L., Willers, J., Hammann‐Haenni, A., Pfaar, O., STOCKER, H., Mueller, P., Renner, W. A., & Bachmann, M. F. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2011.03783.x · Cited by 144
Perrone, L. A., Ahmad, A., Veguilla, V., Lu, X., Smith, G., Katz, J. M., Pushko, P., & Tumpey, T. M. (2009) · Journal of Virology · doi:10.1128/jvi.00207-09 · Cited by 143
Self-citationInfluenza Virus Assembly and Budding at the Viral Budozone
Schmitt, A. P., & Lamb, R. A. (2005) · Advances in virus research · doi:10.1016/s0065-3527(05)64012-2 · Cited by 143
Gambhira, R., Jagu, S., Karanam, B., Gravitt, P. E., Culp, T. D., Christensen, N. D., & Roden, R. B. S. (2007) · Journal of Virology · doi:10.1128/jvi.01577-07 · Cited by 143
Steinmetz, N. F., & Manchester, M. (2009) · Biomacromolecules · doi:10.1021/bm8012742 · Cited by 142
Mastico, R. A., Talbot, S. J., & Stockley, P. G. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-4-541 · Cited by 142
Yu, X., Yuan, X., McLane, M. F., Lee, T. H., & Essex, M. (1993) · Journal of Virology · doi:10.1128/jvi.67.1.213-221.1993 · Cited by 141
H-2Kd-restricted antigenic peptides share a simple binding motif.
Romero, P. J., Corradin, G., Luescher, I. F., & Maryanski, J. L. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.3.603 · Cited by 141
Bessa, J., Köpf, M., & Bachmann, M. F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903949 · Cited by 140
Schmitz, N., Dietmeier, K., Bauer, M., Maudrich, M., Utzinger, S., Muntwiler, S., Saudan, P., & Bachmann, M. F. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090199 · Cited by 139
Bodmer, H. C., Pemberton, R. M., Rothbard, J. B., & Askonas, B. A. (1988) · Cell · doi:10.1016/0092-8674(88)90514-4 · Cited by 138
Wang, B., Quan, F., Kang, S., Bozja, J., Skountzou, I., & Compans, R. W. (2008) · Journal of Virology · doi:10.1128/jvi.01076-08 · Cited by 138
Immunodrugs: Therapeutic VLP-Based Vaccines for Chronic Diseases
Jennings, G. T., & Bachmann, M. F. (2008) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-061008-103129 · Cited by 138
Antibodies from Women Immunized with Gardasil ® Cross-Neutralize HPV 45 Pseudovirions
Smith, J. F., Brownlow, M., Brown, M. J., Kowalski, R., Esser, M. T., Ruiz, W., Barr, E., Brown, D. R., & Bryan, J. T. (2007) · Human Vaccines · doi:10.4161/hv.3.4.4058 · Cited by 137
Simpson-Holley, M., Ellis, D. J., Fisher, D., Elton, D. M., McCauley, J. W., & Digard, P. (2002) · Virology · doi:10.1006/viro.2002.1595 · Cited by 137
The influenza virus ion channel and maturation cofactor M2 is a cholesterol-binding protein
Schroeder, C., Heider, H., Möncke‐Buchner, E., & Lin, T.-I. (2004) · European Biophysics Journal · doi:10.1007/s00249-004-0424-1 · Cited by 137
Vaccination against GIP for the Treatment of Obesity
Fulurija, A., Lutz, T. A., Sladko, K., Osto, M., Wielinga, P. Y., Bachmann, M. F., & Saudan, P. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003163 · Cited by 136
Pattnaik, A. K., & Wertz, G. W. (1990) · Journal of Virology · doi:10.1128/jvi.64.6.2948-2957.1990 · Cited by 136
Induction of Broadly Cross-Reactive Cytotoxic T Cells Recognizing an HIV-1 Envelope Determinant
Takahashi, H., Nakagawa, Y., Pendleton, C. D., et al. (1992) · Science · doi:10.1126/science.1372448 · Cited by 136
Anti-peptide aptamers recognize amino acid sequence and bind a protein epitope.
Xu, W., & Ellington, A. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7475 · Cited by 136
Identification of a Dynein Interacting Domain in the Papillomavirus Minor Capsid Protein L2
Florin, L., Becker, K. A., Lambert, C., Nowak, T., Sapp, C., Strand, D. J., Streeck, R. E., & Sapp, M. J. (2006) · Journal of Virology · doi:10.1128/jvi.00057-06 · Cited by 136
Virus hybrids as nanomaterials for biotechnology
Soto, C. M., & Ratna, B. R. (2010) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2010.07.004 · Cited by 136
Barman, S., & Nayak, D. P. (2000) · Journal of Virology · doi:10.1128/jvi.74.14.6538-6545.2000 · Cited by 136
Imaging Viral Behavior in Mammalian Cells with Self‐Assembled Capsid–Quantum‐Dot Hybrid Particles
Li, F., Zhang, Z., Peng, J., Cui, Z., Pang, D., Li, K., Wei, H., Zhou, Y., Wen, J., & Zhang, X. (2009) · Small · doi:10.1002/smll.200801303 · Cited by 136
Escaping from the Cell: Assembly and Budding of Negative-Strand RNA Viruses
Schmitt, A. P., & Lamb, R. A. (2004) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-06099-5_5 · Cited by 135
Development of a microRNA delivery system based on bacteriophage MS2 virus‐like particles
Pan, Y., Zhang, Y., Jia, T., Zhang, K., Li, J., & Wang, L. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08512.x · Cited by 135
Candidate Recombinant Vaccine for Human B19 Parvovirus
Bansal, G. P., Hatfield, J., Dunn, F. E., et al. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1034 · Cited by 135
Anti-HIV and Anti-Anti-MHC Antibodies in Alloimmune and Autoimmune Mice
Kion, T. A., & Hoffmann, G. W. (1991) · Science · doi:10.1126/science.1909456 · Cited by 135
Role of Repetitive Antigen Patterns for Induction of Antibodies Against Antibodies
Fehr, T. H., Bachmann, M. F., Bucher, E. M., Kalinke, U., Padova, F. E. D., Lang, A. B., Hengartner, H., & Zinkernagel, R. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.10.1785 · Cited by 135
Cellular and molecular biology of HCV infection and hepatitis
Tang, H., & Grisé, H. (2009) · Clinical Science · doi:10.1042/cs20080631 · Cited by 134
Human immunodeficiency virus pseudotypes with expanded cellular and species tropism
Spector, D. H., Wade, E. J., Wright, D. A., Koval, V., Clark, C., Jaquish, D., & Spector, S. A. (1990) · Journal of Virology · doi:10.1128/jvi.64.5.2298-2308.1990 · Cited by 133
Swenson, D. L., Warfield, K. L., Negley, D. L., Schmaljohn, A. L., Aman, M. J., & Bavari, S. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.11.070 · Cited by 133
Mahmood, K., Bright, R. A., Mytle, N., Carter, D. M., Crevar, C. J., Achenbach, J. E., Heaton, P. M., Tumpey, T. M., & Ross, T. M. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.084 · Cited by 133
Identification of proteins encoded by the L1 and L2 open reading frames of human papillomavirus 1a
Doorbar, J., & Gallimore, P. H. (1987) · Journal of Virology · doi:10.1128/jvi.61.9.2793-2799.1987 · Cited by 132
Encapsulation of Phthalocyanine Supramolecular Stacks into Virus-like Particles
Brasch, M., de la Escosura, A., Ma, Y., Uetrecht, C., Heck, A. J. R., Torres⊗, T., & Cornelissen, J. J. L. M. (2011) · Journal of the American Chemical Society · doi:10.1021/ja110752u · Cited by 132
Nayak, D. P., Chambers, T. M., & Akkina, R. (1985) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-70227-3_3 · Cited by 131
Bendz, H., Ruhland, S. C., Pandya, M. J., Hainzl, O., Riegelsberger, S., Bräuchle, C., Mayer, M. P., Büchner, J., Issels, R. D., & Noeßner, E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704129200 · Cited by 130
Burleigh, L. M., Calder, L. J., Skehel, J. J., & Steinhauer, D. A. (2004) · Journal of Virology · doi:10.1128/jvi.79.2.1262-1270.2005 · Cited by 130
In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes
Reddy, R., Zhou, F., Nair, S. K., Huang, L., & Rouse, B. T. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.5.1585 · Cited by 129
Tumban, E., Peabody, J., Peabody, D. S., & Chackerian, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023310 · Cited by 129
Galarza, J. M., Latham, T. E., & Cupo, A. (2005) · Viral Immunology · doi:10.1089/vim.2005.18.244 · Cited by 129
Chan, S. Y., Bernard, H., Ong, C. K., Chan, S. P., Hofmann, B., & Delius, H. (1992) · Journal of Virology · doi:10.1128/jvi.66.10.5714-5725.1992 · Cited by 128
A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins
Bredenbeek, P. J., Molenkamp, R., Spaan, W. J. M., Deubel, V., Marianneau, P., Salvato, M. S., Moshkoff, D. A., Zapata, J. C., Tikhonov, I., Patterson, J. L., et al. (2006) · Virology · doi:10.1016/j.virol.2005.12.001 · Cited by 128
Buckyballs Meet Viral Nanoparticles: Candidates for Biomedicine
Steinmetz, N. F., Hong, V., Spoerke, E. D., Lu, P., Breitenkamp, K., Finn, M. G., & Manchester, M. (2009) · Journal of the American Chemical Society · doi:10.1021/ja902293w · Cited by 128
Murawski, M. R., McGinnes, L. W., Finberg, R. W., Kurt‐Jones, E. A., Massare, M. J., Smith, G., Heaton, P. M., Fraire, A. E., & Morrison, T. G. (2009) · Journal of Virology · doi:10.1128/jvi.01709-09 · Cited by 127
Role of Surface Charge Density in Nanoparticle-Templated Assembly of Bromovirus Protein Cages
Daniel, M., Tsvetkova, I. B., Quinkert, Z. T., et al. (2010) · ACS Nano · doi:10.1021/nn1005073 · Cited by 126
Hyatt, A. D., Zhao, Y., & Roy, P. (1993) · Virology · doi:10.1006/viro.1993.1167 · Cited by 125
Further Evidence that Papillomavirus Capsids Exist inTwo DistinctConformations
Selinka, H., Giroglou, T., Nowak, T., Christensen, N. D., & Sapp, M. J. (2003) · Journal of Virology · doi:10.1128/jvi.77.24.12961-12967.2003 · Cited by 125
Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx
Wu, X., Liu, H., Xiao, H., Kim, J., Seshaiah, P., Natsoulis, G., Boeke, J. D., Hahn, B. H., & Kappes, J. C. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3389-3398.1995 · Cited by 125
Viruslike Particle Vaccine Induces Protection Against Respiratory Syncytial Virus Infection in Mice
Quan, F.-S., Kim, Y., Lee, S., Yi, H., Kang, S.-M., Bozja, J., Moore, M. L., & Compans, R. W. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir474 · Cited by 125
Klavinskis, L. S., Whitton, J. L., & Oldstone, M. B. A. (1989) · Journal of Virology · doi:10.1128/jvi.63.10.4311-4316.1989 · Cited by 125
Storni, T., Lechner, F., Erdmann, I., Bächi, T., Jegerlehner, A., Dumrese, T., Kündig, T. M., Ruedl, C., & Bachmann, M. F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.2880 · Cited by 125
Assembly Of Animal Viruses At Cellular Membranes
Stephens, E. B., & Compans, R. W. (1988) · Annual Review of Microbiology · doi:10.1146/annurev.mi.42.100188.002421 · Cited by 125
Christensen, N. D., Cladel, N. M., Reed, C. A., Budgeon, L. R., Embers, M. E., Skulsky, D., McClements, W. L., Ludmerer, S. W., & Jansen, K. U. (2001) · Virology · doi:10.1006/viro.2001.1220 · Cited by 123
Robinson, W. E., Kawamura, T., Górny, M. K., Lake, D. F., Xu, J. Y., Matsumoto, Y., Sugano, T., Masuho, Y., Mitchell, W. M., & Hersh, E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.3185 · Cited by 122
Paliard, X., Liu, Y., Wagner, R., Wolf, H. J., Baenziger, J., & Walker, C. M. (2000) · AIDS Research and Human Retroviruses · doi:10.1089/088922200309368 · Cited by 121
Chackerian, B., Rangel, M., Hunter, Z. N., & Peabody, D. S. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.059 · Cited by 121
Moore, J. P., Sattentau, Q. J., Yoshiyama, H., Thali, M., Charles, M., Sullivan, N. J., Poon, S. W., Fung, M. S. C., Traincard, F., & Pinkus, M. S. (1993) · Journal of Virology · doi:10.1128/jvi.67.10.6136-6151.1993 · Cited by 120
Barman, S., Ali, A., Hui, E. K., Adhikary, L., & Nayak, D. P. (2001) · Virus Research · doi:10.1016/s0168-1702(01)00266-0 · Cited by 120
Hepatitis B small surface antigen particles are octahedral
Gilbert, R. J. C., Beales, L., Blond, D., Simon, M. N., Lin, B. Y., Chisari, F. V., Stuart, D. I., & Rowlands, D. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505062102 · Cited by 120
Immunogenicity Testing in Human Papillomavirus Virus‐Like‐Particle Vaccine Trials
Schiller, J. T., & Lowy, D. R. (2009) · The Journal of Infectious Diseases · doi:10.1086/599988 · Cited by 119
Barillari, G., & Ensoli, B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.310-326.2002 · Cited by 119
Influenza virus NS1 protein stimulates translation of the M1 protein
Enami, K., Sato, T., Nakada, S., & Enami, M. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.1432-1437.1994 · Cited by 119
Cowpea Mosaic Virus Nanoparticles Target Surface Vimentin on Cancer Cells
Steinmetz, N. F., Cho, C., Ablack, A. L., Lewis, J. D., & Manchester, M. (2011) · Nanomedicine · doi:10.2217/nnm.10.136 · Cited by 118
Multivalent Display and Receptor‐Mediated Endocytosis of Transferrin on Virus‐Like Particles
Banerjee, D., Liu, A. P., Voss, N. R., Schmid, S. L., & Finn, M. G. (2010) · ChemBioChem · doi:10.1002/cbic.201000125 · Cited by 118
Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles
Chackerian, B., Lowy, D. R., & Schiller, J. T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2373 · Cited by 117
Li, M., Schmitt, P. T., Li, Z. Y., McCrory, T. S., He, B., & Schmitt, A. P. (2009) · Journal of Virology · doi:10.1128/jvi.00421-09 · Cited by 117
Filamin A is required for vimentin-mediated cell adhesion and spreading
Kim, H., Nakamura, F., Lee, W., Shifrin, Y., Arora, P. D., & McCulloch, C. A. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00323.2009 · Cited by 116
Burns, D. P. W., Collignon, C., & Desrosiers, R. C. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.4104-4113.1993 · Cited by 116
Virus-like particles as HIV-1 vaccines
Doan, L. X., Li, M., Chen, C., & Yao, Q. C. (2004) · Reviews in Medical Virology · doi:10.1002/rmv.449 · Cited by 116
Therapeutic vaccination for chronic diseases: a new class of drugs in sight
Bachmann, M. F., & Dyer, M. R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1284 · Cited by 115
Replication of the influenza virus genome
Smith, G. L., & Hay, A. J. (1982) · Virology · doi:10.1016/0042-6822(82)90323-3 · Cited by 115
Block, S. L., Brown, D. R., Chatterjee, A., Gold, M. A., Sings, H. L., Meibohm, A. R., Dana, A., Haupt, R. M., Barr, E., Tamms, G. M., et al. (2010) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181b77906 · Cited by 115
Papsidero, L. D., Sheu, M., & Ruscetti, F. W. (1989) · Journal of Virology · doi:10.1128/jvi.63.1.267-272.1989 · Cited by 115
A Poliovirus Neutralization Epitope Expressed on Hybrid Hepatitis B Surface Antigen Particles
Delpeyroux, F., Chenciner, N., Lim, A., Malpièce, Y., Blondel, B., Crainic, R., van der Werf, S., & Streeck, R. E. (1986) · Science · doi:10.1126/science.2425433 · Cited by 114
Xu, B., deWaal, R. M., Mor‐Vaknin, N., Hibbard, C., Markovitz, D. M., & Kahn, M. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.20.9198-9206.2004 · Cited by 114
Encapsidation of heterologous RNAs by bacteriophage MS2 coat protein
Pickett, G., & Peabody, D. S. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.19.4621 · Cited by 113
Khanna, R., Moss, D. J., & Burrows, S. R. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01328.x · Cited by 112
Structures of virus and virus-like particles
Johnson, J. (2000) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(00)00073-7 · Cited by 112
Norwalk virus-like particles as vaccines
Herbst‐Kralovetz, M. M., Mason, H. S., & Chen, Q. (2010) · Expert Review of Vaccines · doi:10.1586/erv.09.163 · Cited by 111
Potato Virus X as a Novel Platform for Potential Biomedical Applications
Steinmetz, N. F., Mertens, M. E., Taurog, R. E., Johnson, J. E., Commandeur, U., Fischer, R., & Manchester, M. (2009) · Nano Letters · doi:10.1021/nl9035753 · Cited by 111
Kreider, J. W., & Bartlett, G. L. (1981) · Advances in cancer research · doi:10.1016/s0065-230x(08)60909-4 · Cited by 110
Immune escape by Epstein Barr virus associated malignancies
Münz, C., & Moormann, A. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.10.002 · Cited by 110
Cell-Specific Delivery of Bacteriophage-Encapsidated Ricin A Chain
Wu, M., Brown, W. L., & Stockley, P. G. (1995) · Bioconjugate Chemistry · doi:10.1021/bc00035a013 · Cited by 110
Perez, L. G., Davis, G. L., & Hunter, E. (1987) · Journal of Virology · doi:10.1128/jvi.61.10.2981-2988.1987 · Cited by 109
RNA-binding proteins that inhibit RNA virus infection
Zhu, J. K., Gopinath, K., Murali, A., Yi, G., Hayward, S. D., Zhu, H., & Kao, C. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611617104 · Cited by 108
Epidemiology and Control of Lassa Fever
McCormick, J. B. (1987) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-71726-0_3 · Cited by 107
WHITE, P. J., Squirrell, D. J., Arnaúd, P., Lowe, C. R., & Murray, J. A. H. (1996) · Biochemical Journal · doi:10.1042/bj3190343 · Cited by 107
Incorporation of chimeric gag protein into retroviral particles
Weldon, R. A., Erdie, C. R., Oliver, M. G., & Wills, J. W. (1990) · Journal of Virology · doi:10.1128/jvi.64.9.4169-4179.1990 · Cited by 107
Optimization of Dendritic Cell Loading With Tumor Cell Lysates for Cancer Immunotherapy
Hatfield, P., Merrick, A. E., West, E. J., O’Donnell, D., Selby, P. J., Vile, R. G., & Melcher, A. A. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31818213df · Cited by 106
A Virus-Like Particle-Based Epstein-Barr Virus Vaccine
Ruiss, R., Jochum, S., Wanner, G., Reisbach, G., Hammerschmidt, W., & Zeidler, R. (2011) · Journal of Virology · doi:10.1128/jvi.05598-11 · Cited by 106
Mutational Analysis of Conserved Amino Acids in the Influenza A Virus Nucleoprotein
Li, Z., Watanabe, T., Hatta, M., Watanabe, S., Nanbo, A., Ozawa, M., Kakugawa, S., Shimojima, M., Yamada, S., Neumann, G., et al. (2009) · Journal of Virology · doi:10.1128/jvi.02642-08 · Cited by 106
Chackerian, B., Durfee, M. R., & Schiller, J. T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.5816 · Cited by 105
Fine structure of influenza A virus observed by electron cryo‐microscopy.
Fujiyoshi, Y., Kume, N., Sakata, K., et al. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06264.x · Cited by 105
Ye, L., Lin, J., Sun, Y., Bennouna, S., Lo, M. K., Wu, Q., Bu, Z., Pulendran, B., Compans, R. W., & Yang, C. (2006) · Virology · doi:10.1016/j.virol.2006.03.021 · Cited by 104
Poovorawan, Y., Chongsrisawat, V., Theamboonlers, A., Bock, H. L., Leyssen, M., & Jacquet, J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.10.074 · Cited by 104
Suci, P. A., Varpness, Z. B., Gillitzer, E., Douglas, T., & Young, M. (2007) · Langmuir · doi:10.1021/la7021424 · Cited by 103
Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells
Šmahel, M., Šíma, P., Ludvíková, V., & Vonka, V. (2001) · Virology · doi:10.1006/viro.2000.0794 · Cited by 103
Haynes, J. R., Dokken, L., Wiley, J. A., Cawthon, A. G., Bigger, J. E., Harmsen, A. G., & Richardson, C. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.11.011 · Cited by 103
McGinnes, L. W., Gravel, K. A., Finberg, R. W., Kurt‐Jones, E. A., Massare, M. J., Smith, G., Schmidt, M. R., & Morrison, T. G. (2010) · Journal of Virology · doi:10.1128/jvi.01861-10 · Cited by 103
tRNA elements mediate the assembly of an icosahedral RNA virus
Choi, Y. G., Dreher, T. W., & Rao, A. L. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022618199 · Cited by 103
Protein kinases required for segregation of vimentin filaments in mitotic process
Yasui, Y., Goto, H., Matsui, S., Manser, E. J., Lim, L., Nagata, K., & Inagaki, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204407 · Cited by 102
Vaccines to Prevent Infections by Oncoviruses
Schiller, J. T., & Lowy, D. R. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134019 · Cited by 101
Khor, R., McElroy, L. J., & Whittaker, G. R. (2003) · Traffic · doi:10.1046/j.1398-9219.2003.0140.x · Cited by 101
Betancourt, A. A., González-Delgado, C. A., Cinza, Z., Martínez, J. S. G., Ríos, G. V., Aureoles-Roselló, S. R. M., Zaldívar, R. A., Guzmán, M. A., Baile, N. F., Reyes, P. A. D., et al. (2007) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2006.09.010 · Cited by 101
RNA Bacteriophage Capsid-Mediated Drug Delivery and Epitope Presentation
Brown, W. L., Mastico, R. A., Wu, M., Heal, K. G., Adams, C. J., Murray, J. B., Simpson, J. C., Lord, J. M., Taylor-Robinson, A. W., & Stockley, P. G. (2002) · Intervirology · doi:10.1159/000067930 · Cited by 101
Eichler, R., Strecker, T., Kolesnikova, L., ter Meulen, J., Weissenhorn, W., Becker, S., Klenk, H. D., Garten, W., & Lenz, O. (2004) · Virus Research · doi:10.1016/j.virusres.2003.11.017 · Cited by 100
Virus-like particles: Designing an effective AIDS vaccine
Young, K. R., McBurney, S. P., Karkhanis, L. U., & Ross, T. M. (2006) · Methods · doi:10.1016/j.ymeth.2006.05.024 · Cited by 100
Goon, P. K. C., Biancardi, A., Fast, N. M., Igakura, T., Hanon, E., Mosley, A. J., Asquith, B., Gould, K. G., Marshall, S. E., Taylor, G. P., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/420832 · Cited by 100
Immunogenic and protective properties of rabies virus glycoprotein expressed by baculovirus vectors
Prehaud, C. J. N., Takehara, K., Flamand, A., & Bishop, D. H. L. (1989) · Virology · doi:10.1016/0042-6822(89)90551-5 · Cited by 99
Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection
Warfield, K. L., Swenson, D. L., Negley, D. L., Schmaljohn, A. L., Aman, M. J., & Bavari, S. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.01.063 · Cited by 99
Recombinant rna phage qβ capsid particles synthesized and self-assembled in escherichia coli
Kozlovska, T. M., Cielēns, I., Dreilina, D., Dišlers, A., Baumanis, V., Ose, V., & Pumpēns, P. (1993) · Gene · doi:10.1016/0378-1119(93)90261-z · Cited by 99
Transmission of human herpesvirus 8: an update
Pica, F., & Volpi, A. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3280143919 · Cited by 99
Nardin, E. H., Oliveira, G. A., Calvo‐Calle, J. M., Wetzel, K., Maier, C., Birkett, A. J., Sarpotdar, P. P., Corado, M. L., Thornton, G. B., & Schmidt, A. (2004) · Infection and Immunity · doi:10.1128/iai.72.11.6519-6527.2004 · Cited by 99
Pushko, P., Tumpey, T. M., Hoeven, N. V., Belser, J. A., Robinson, R., Nathan, M., Smith, G., Wright, D. C., & Bright, R. A. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.02.059 · Cited by 99
Self-citationSpohn, G., Jennings, G. T., Martina, B. E. E., Keller, I., Beck, M., Pumpens, P., Osterhaus, A. D. M. E., & Bachmann, M. F. (2010) · Virology Journal · doi:10.1186/1743-422x-7-146 · Cited by 99
Self-citationCaldeira, J. C., Medford, A., Kines, R. C., Lino, C. A., Schiller, J. T., Chackerian, B., & Peabody, D. S. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.04.049 · Cited by 98
Phenotypic Mixing of Envelope Proteins of the Parainfluenza Virus SV5 and Vesicular Stomatitis Virus
Choppin, P. W., & Compans, R. W. (1970) · Journal of Virology · doi:10.1128/jvi.5.5.609-616.1970 · Cited by 97
Recombinant vaccine for canine parvovirus in dogs
de Turiso, J. A. L., Cortés, E., Martínez, C., de Ybáñez, R. R., Simarro, I., Vela, C., & Casal, J. I. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.2748-2753.1992 · Cited by 97
Cell Targeting with Hybrid Qβ Virus‐Like Particles Displaying Epidermal Growth Factor
Pokorski, J. K., Hovlid, M. L., & Finn, M. G. (2011) · ChemBioChem · doi:10.1002/cbic.201100469 · Cited by 97
A Rapid and Simple Colorimetric Test for the Study of Anti-HIV Agents
Schwartz, O., Hénin, Y., Maréchal, V., & Montagnier, L. (1988) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1988.4.441 · Cited by 97
Mascola, J. R., Mathieson, B. J., Zack, P. M., Walker, M. C., Halstead, S. B., & Burke, D. S. (1993) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1993.9.1175 · Cited by 96
Identification of Structural Domains Involved in Astrovirus Capsid Biology
Krishna, N. K. (2005) · Viral Immunology · doi:10.1089/vim.2005.18.17 · Cited by 96
Development of hepatitis C virus vaccines: challenges and progress
Stoll‐Keller, F., Barth, H., Fafi‐Kremer, S., Zeisel, M. B., & Baumert, T. F. (2009) · Expert Review of Vaccines · doi:10.1586/14760584.8.3.333 · Cited by 96
Single M13 bacteriophage tethering and stretching
Khalil, A. S., Ferrer, J. M., Brau, R. R., Kottmann, S. T., Noren, C. J., Lang, M. J., & Belcher, A. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605727104 · Cited by 96
The role of myristoylation in the membrane association of the Lassa virus matrix protein Z
Strecker, T., Maisa, A., Daffis, S., Eichler, R., Lenz, O., & Garten, W. (2006) · Virology Journal · doi:10.1186/1743-422x-3-93 · Cited by 95
Ramqvist, T., Andreasson, K., & Dalianis, T. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.7.997 · Cited by 94
Haigwood, N. L., Shuster, J. R., Moore, G. K., Lee, H., Skiles, P. V., Higgins, K. W., Barr, P. J., George-Nascimento, C., & Steimer, K. S. (1990) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1990.6.855 · Cited by 94
Functional domains of HIV-1gag-polyprotein expressed in baculovirus-infected cells
Royer, M., Cérutti, M., Gay, B., Hong, S. S., Devauchelle, G., & Boulanger, P. A. (1991) · Virology · doi:10.1016/0042-6822(91)90861-5 · Cited by 94
Individual expression of influenza virus PA protein induces degradation of coexpressed proteins
Sanz‐Ezquerro, J. J., de la Luna, S., Ortı́n, J., et al. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2420-2426.1995 · Cited by 92
Lenzi, P., Scotti, N., Alagna, F., Tornesello, M. L., Pompa, A., Vitale, A., Stradis, A. D., Monti, L. M., Grillo, S., Buonaguro, L., et al. (2008) · Transgenic Research · doi:10.1007/s11248-008-9186-3 · Cited by 91
Yamshchikov, G. V., Ritter, G., Vey, M., & Compans, R. W. (1995) · Virology · doi:10.1006/viro.1995.9955 · Cited by 91
Peabody, D. S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39417-7 · Cited by 90
Zhao, G., Lin, Y., Du, L., Guan, J., Sun, S., Sui, H., Kou, Z., Chan, C. C. S., Guo, Y., Jiang, S., et al. (2010) · Virology Journal · doi:10.1186/1743-422x-7-9 · Cited by 90
Active immunization with IL‐1 displayed on virus‐like particles protects from autoimmune arthritis
Spohn, G., Keller, I., Beck, M., Grest, P., Jennings, G. T., & Bachmann, M. F. (2008) · European Journal of Immunology · doi:10.1002/eji.200737989 · Cited by 89
Virus‐like particles induce robust human T‐helper cell responses
Braun, M., Jandus, C., Maurer, P., Hammann‐Haenni, A., Schwarz, K., Bachmann, M. F., Speiser, D. E., & Romero, P. J. (2011) · European Journal of Immunology · doi:10.1002/eji.201142064 · Cited by 88
Ohuchi, M., Cramer, A., Vey, M., Ohuchi, R., Garten, W., & Klenk, H. (1994) · Journal of Virology · doi:10.1128/jvi.68.2.920-926.1994 · Cited by 88
Priming of influenza virus-specific cytotoxic T lymphocytes vivo by short synthetic peptides
Gao, X. M., Zheng, B. Q., Liew, F. Y., Brett, S. J., & Tite, J. P. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.10.3268 · Cited by 87
IL-4/Stat6 activities correlate with apoptosis and metastasis in colon cancer cells
Li, B. H., Yang, X. Z., Li, P. D., Yuan, Q., Liu, X. H., Yuan, J., & Zhang, W. J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.02.052 · Cited by 87
Sanchez-Perez, L. A., Kottke, T. J., Díaz, R. M., Ahmed, A. U., Thompson, J., Chong, H., Melcher, A. A., Holmen, S. L., Daniels, G. A., & Vile, R. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3216 · Cited by 86
Talbot, P. J., Salmi, A. A., Knobler, R. L., & Buchmeier, M. J. (1984) · Virology · doi:10.1016/0042-6822(84)90032-1 · Cited by 86
Overton, H. A., Fujii, Y. R., Price, I. R., & Jones, I. M. (1989) · Virology · doi:10.1016/0042-6822(89)90357-7 · Cited by 86
Wu, L. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00428-6 · Cited by 86
Tong, T., Crooks, E. T., Osawa, K., & Binley, J. Μ. (2012) · Journal of Virology · doi:10.1128/jvi.06938-11 · Cited by 86
Delivery of antisense oligonucleotides to leukemia cells by RNA bacteriophage capsids
Wu, M., Sherwin, T., Brown, W. L., & Stockley, P. G. (2005) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2004.11.011 · Cited by 86
Immunotherapy for Advanced Melanoma
Fang, L., Lonsdorf, A. S., & Hwang, S. T. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.101 · Cited by 85
Wei, B., Wei, Y., Zhang, K., Wang, J., Xu, R., Zhan, S., Lin, G., Wang, W., Liu, M., Wang, L., et al. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.07.086 · Cited by 85
Habjan, M., Penski, N., Wagner, V., Spiegel, M., Överby, A. K., Kochs, G., Huiskonen, J. T., & Weber, F. (2009) · Virology · doi:10.1016/j.virol.2008.12.011 · Cited by 85
Gedvilaitė, A., Frömmel, C., Sasnauskas, K., Micheel, B., Özel, M., Behrsing, O., Staniulis, J., Jandrig, B., Scherneck, S., & Ulrich, R. G. (2000) · Virology · doi:10.1006/viro.2000.0392 · Cited by 85
Wang, B., Liu, W., Kang, S., Alam, M. S., Huang, C., Ye, L., Sun, Y., Li, Y., Kothe, D. L., Pushko, P., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00542-07 · Cited by 85
Self-citationAguilera, R., Saffie, C., Tittarelli, A., González, F. E., Ramírez, M., Reyes, D., Pereda, C., Hevia, D., García‐Salum, T., Salazar, L., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2384 · Cited by 85
Filovirus‐Like Particles Produced in Insect Cells: Immunogenicity and Protection in Rodents
Warfield, K. L., Posten, N. A., Swenson, D. L., Olinger, G. G., Esposito, D., Gillette, W., Hopkins, R. F., Costantino, J. A., Panchal, R. G., Hartley, J. L., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/520612 · Cited by 85
Sugahara, F., Uchiyama, T., Watanabe, H., Shimazu, Y., Kuwayama, M., Fujii, Y., Kiyotani, K., Adachi, A., Kohno, N., Yoshida, T., et al. (2004) · Virology · doi:10.1016/j.virol.2004.04.019 · Cited by 84
Inoue, T., Kawano, M., Takahashi, R., Tsukamoto, H., Enomoto, T., Imai, T., Kataoka, K., & Handa, H. (2008) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2007.12.006 · Cited by 83
A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines
Middelberg, A. P. J., Rivera-Hernández, T., Wibowo, N., Lua, L. H. L., Fan, Y., Magor, G. W., Chang, C. J., Chuan, Y. P., Good, M. F., & Batzloff, M. R. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.05.075 · Cited by 83
Rasmussen, L. A., Battles, J. K.-L. K., Ennis, W. H., Nagashima, K., & Gonda, M. A. (1990) · Virology · doi:10.1016/0042-6822(90)90341-n · Cited by 83
Shchelkunov, S. N., Salyaev, R. K., Pozdnyakov, S. G., Rekoslavskaya, N. I., Ae, N., Ryzhova, T. S., Sumtsova, V. M., Pakova, N. V., Mishutina, U. O., Копытина, Т. В., et al. (2006) · Biotechnology Letters · doi:10.1007/s10529-006-9028-4 · Cited by 83
Andeweg, A. C., Leeflang, P., Osterhaus, A. D. M. E., et al. (1993) · Journal of Virology · doi:10.1128/jvi.67.6.3232-3239.1993 · Cited by 82
Fisher‐Hoch, S. P., & McCormick, J. B. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.2.189 · Cited by 82
Ding, F., Wang, F., Lu, Y., Li, K., Wang, K.-H., He, X., & Sun, S. (2009) · Hepatology · doi:10.1002/hep.22816 · Cited by 82
Peacey, M., Wilson, S., Baird, M. A., & Ward, V. K. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21518 · Cited by 82
Casabona, J. C., Macleod, J. M. L., Loureiro, M. E., Gomez, G. A., & López, N. (2009) · Journal of Virology · doi:10.1128/jvi.00329-09 · Cited by 82
Royer, M., Hong, S. S., Gay, B., Cérutti, M., & Boulanger, P. A. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.3230-3235.1992 · Cited by 81
Rutgers, T., Gordon, D. M., GATHOYE, A., Hollingdale, M. R., Hockmeyer, W. T., Rosenberg, M. J., & Wilde, M. D. (1988) · Nature Biotechnology · doi:10.1038/nbt0988-1065 · Cited by 81
Matić, S., Rinaldi, R., Masenga, V., & Noris, E. (2011) · BMC Biotechnology · doi:10.1186/1472-6750-11-106 · Cited by 81
Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus
Aresté, C., & Blackbourn, D. J. (2009) · Trends in Microbiology · doi:10.1016/j.tim.2008.12.001 · Cited by 81
Haynes, J. R., Cunningham, J., von Seefried, A., Lennick, M., Garvin, R. T., & Shen, S.-H. (1986) · Nature Biotechnology · doi:10.1038/nbt0786-637 · Cited by 80
Hannan, L. A., & Edidin, M. A. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.133.6.1265 · Cited by 80
Kawana, K., Yoshikawa, H., Taketani, Y., Yoshiike, K., & Kanda, T. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.10298-10300.1998 · Cited by 80
Wilson, C. A., Reitz, M. S., Okayama, H., & Eiden, M. (1989) · Journal of Virology · doi:10.1128/jvi.63.5.2374-2378.1989 · Cited by 79
Pushko, P., Pearce, M. B., Ahmad, A., Tretyakova, I., Smith, G., Belser, J. A., & Tumpey, T. M. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.06.068 · Cited by 79
Self-citationSwenson, D. L., Warfield, K. L., Larsen, T., Alves, D. A., Coberley, S. S., & Bavari, S. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.4.417 · Cited by 79
Primary prevention of HTLV-1 in Japan.
Hino, S., Katamine, S., Miyata, H., Tsuji, Y., Yamabe, T., & Miyamoto, T. (1997) · PubMed · Cited by 79
Vaney, M. C., & Rey, F. A. (2011) · Cellular Microbiology · doi:10.1111/j.1462-5822.2011.01653.x · Cited by 78
Efficacy of Human Papillomavirus Vaccines
Medeiros, L. R., Rosa, D. D., da Rosa, M. I., Bozzetti, M. C., & Zanini, R. R. (2009) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181a3d100 · Cited by 78
Baculovirus expression vectors with single strand capability
Livingstone, C., & Jones, I. M. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.6.2366 · Cited by 78
Production and of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins
Kent, K. A., Gritz, L. R., Stallard, G., Cranage, M. P., Collignon, C., Thiriart, C., Corcoran, T., Silvera, P. M., & Stott, E. J. (1991) · AIDS · doi:10.1097/00002030-199107000-00006 · Cited by 77
Complementation of RNA Binding Site Mutations in MS2 Coat Protein Heterodimers
Peabody, D. S., & Lim, F. B. H. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.12.2352 · Cited by 76
Vaccine Potential of Nipah Virus-Like Particles
Walpita, P., Barr, J. A., Sherman, M. B., Basler, C. F., & Wang, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018437 · Cited by 76
Lico, C., Mancini, C., Italiani, P., Betti, C., Boraschi, D., Benvenuto, E., & Baschieri, S. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.045 · Cited by 76
Griffiths, J., Harris, S., Layton, G. T., Berrie, E. L., French, T. J., Burns, N. R., Adams, S. E., & Kingsman, A. J. (1993) · Journal of Virology · doi:10.1128/jvi.67.6.3191-3198.1993 · Cited by 76
Subunit Fusion Confers Tolerance to Peptide Insertions in a Virus Coat Protein
Peabody, D. S. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0312 · Cited by 75
Speir, J. A., Bothner, B. B., Qu, C., Willits, D. A., Young, M., & Johnson, J. E. (2006) · Journal of Virology · doi:10.1128/jvi.80.7.3582-3591.2006 · Cited by 75
Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection
Karanam, B., Jagu, S., Huh, W. K., & Roden, R. B. S. (2009) · Immunology and Cell Biology · doi:10.1038/icb.2009.13 · Cited by 74
Zurzolo, C., Polistina, C., Saini, M., Gentile, R., Aloj, L., Migliaccio, G., Bonatti, S., & Nitsch, L. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.117.3.551 · Cited by 74
Donnelly, J., Ulmer, J. B., Hawe, L. A., Friedman, A., Shi, X.-P., Leander, K. R., Shiver, J. W., Oliff, A., Martínez, D., & Montgomery, D. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3530 · Cited by 73
Peptide selection by class I molecules of the major histocompatibility complex
Elliott, T. J., Smith, M., Driscoll, P. C., & McMichael, A. J. (1993) · Current Biology · doi:10.1016/0960-9822(93)90219-e · Cited by 73
Role of ATP in Influenza Virus Budding
Hui, E. K., & Nayak, D. P. (2001) · Virology · doi:10.1006/viro.2001.1181 · Cited by 73
Rubella Virus Capsid Protein Interacts with Poly(A)-Binding Protein and Inhibits Translation
Ilkow, C. S., Mancinelli, V., Beatch, M. D., & Hobman, T. C. (2008) · Journal of Virology · doi:10.1128/jvi.02732-07 · Cited by 73
Immunogenicity and Protective Efficacy of Replication-Incompetent Influenza Virus-Like Particles
Watanabe, T., Watanabe, S., Neumann, G., Kida, H., & Kawaoka, Y. (2002) · Journal of Virology · doi:10.1128/jvi.76.2.767-773.2002 · Cited by 73
Polarized Budding of Measles Virus Is Not Determined by Viral Surface Glycoproteins
Maisner, A., Klenk, H. D., & Herrler, G. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.5276-5278.1998 · Cited by 72
de la Rosa, G. P., Monroy, A., Mora‐García, M. D. L., Reynaga‐Peña, C. G., Hernández‐Montes, J., Weiss‐Steider, B., & Gómez-Lim, M. Á. (2009) · Virology Journal · doi:10.1186/1743-422x-6-2 · Cited by 72
Pushko, P., Kort, T., Nathan, M., Pearce, M. B., Smith, G., & Tumpey, T. M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.04.093 · Cited by 72
Self-citationAnnamalai, P., & Rao, A. L. N. (2006) · Journal of Virology · doi:10.1128/jvi.01186-06 · Cited by 72
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations
Jeevanandam, J., Barhoum, A., Chan, Y. S., Dufresne, A., & Danquah, M. K. (2018) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.9.98 · Cited by 3,297
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,730
mTOR regulates memory CD8 T-cell differentiation
Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., & Ahmed, R. (2009) · Nature · doi:10.1038/nature08155 · Cited by 1,575
A DNA transfection system for generation of influenza A virus from eight plasmids
Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G., & Webster, R. G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100133697 · Cited by 1,565
Metadata
- Authors
- Pushko, P., Pumpens, P., & Grens, E.
- Venue
- Intervirology
- Publisher
- S. Karger AG
- Published
- 2013
- Volume
- 56
- Issue
- 3
- Pages
- 141-165
- ISSN
- 0300-5526 (ISSN-L)
- 1423-0100
- OpenAlex
- W2046182783
- Cited by
- 5,950
- References
- 770
- FWCI
- 295.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.